EVOLUS, INC. (EOLS)
Clinical trial NCT05481931 updates: 1. completion date: 2026-02-04 → 2026-04-13 2. primary completion date: 2026-02-04 → 2026-04-13
Clinical trial NCT05481931 updates: 1. completion date: 2026-02-04 → 2026-04-13 2. primary completion date: 2026-02-04 → 2026-04-13
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical